These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

479 related articles for article (PubMed ID: 34018314)

  • 1. Secondary sclerosing cholangitis as cause of persistent jaundice in patients with severe COVID-19.
    Bütikofer S; Lenggenhager D; Wendel Garcia PD; Maggio EM; Haberecker M; Reiner CS; Brüllmann G; Buehler PK; Gubler C; Müllhaupt B; Jüngst C; Morell B
    Liver Int; 2021 Oct; 41(10):2404-2417. PubMed ID: 34018314
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Secondary Sclerosing Cholangitis After SARS-CoV2: ICU Ketamine Use or Virus-Specific Biliary Tropism and Injury in the Context of Biliary Ischemia in Critically Ill Patients?
    Bartoli A; Cursaro C; Seferi H; Andreone P
    Hepat Med; 2023; 15():93-112. PubMed ID: 37547355
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Progressive cholestasis and associated sclerosing cholangitis are frequent complications of COVID-19 in patients with chronic liver disease.
    Hartl L; Haslinger K; Angerer M; Semmler G; Schneeweiss-Gleixner M; Jachs M; Simbrunner B; Bauer DJM; Eigenbauer E; Strassl R; Breuer M; Kimberger O; Laxar D; Lampichler K; Halilbasic E; Stättermayer AF; Ba-Ssalamah A; Mandorfer M; Scheiner B; Reiberger T; Trauner M
    Hepatology; 2022 Dec; 76(6):1563-1575. PubMed ID: 35596929
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Persistent Cholestatic Injury and Secondary Sclerosing Cholangitis in COVID-19 Patients.
    Shih AR; Hatipoglu D; Wilechansky R; Goiffon R; Deshpande V; Misdraji J; Chung RT
    Arch Pathol Lab Med; 2022 Oct; 146(10):1184-1193. PubMed ID: 35657750
    [TBL] [Abstract][Full Text] [Related]  

  • 5. COVID-19-associated secondary sclerosing cholangitis - A case series of 4 patients.
    Ferreira FB; Mourato M; Bragança S; Paulo JB; Sismeiro R; Pereira A; Mónica AN; Lourenço LC; Cardoso M
    Clin Res Hepatol Gastroenterol; 2022 Dec; 46(10):102048. PubMed ID: 36347499
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Corona again? SSC after a severe COVID-disease.
    Arnstadt B; Zillinger C; Treitl M; Allescher HD
    Z Gastroenterol; 2021 Dec; 59(12):1304-1308. PubMed ID: 34666402
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Secondary Sclerosing Cholangitis due to Severe COVID-19: An Emerging Disease Entity?
    Seifert M; Kneiseler G; Dechene A
    Digestion; 2023; 104(4):306-312. PubMed ID: 36889285
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatobiliary long-term consequences of COVID-19: dramatically increased rate of secondary sclerosing cholangitis in critically ill COVID-19 patients.
    Leonhardt S; Jürgensen C; Frohme J; Grajecki D; Adler A; Sigal M; Leonhardt J; Voll JM; Kruse JM; Körner R; Eckardt KU; Janssen HJ; Gebhardt V; Schmittner MD; ; Frey C; Müller-Ide H; Bauer M; Thibeault C; Kurth F; Sander LE; Müller T; Tacke F
    Hepatol Int; 2023 Dec; 17(6):1610-1625. PubMed ID: 37119516
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Secondary Sclerosing Cholangitis in Critically Ill Patients: Clinical Presentation, Cholangiographic Features, Natural History, and Outcome: A Series of 16 Cases.
    Leonhardt S; Veltzke-Schlieker W; Adler A; Schott E; Eurich D; Faber W; Neuhaus P; Seehofer D
    Medicine (Baltimore); 2015 Dec; 94(49):e2188. PubMed ID: 26656347
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Secondary sclerosing cholangitis following major burn.
    Ben-Ari Z; Levingston D; Weitzman E; Haviv-Yadid Y; Cohen-Ezra O; Weiss P; Zuckerman E; Inbar Y; Amitai M; Rimon U; Goder M; Haik J
    Ann Hepatol; 2015; 14(5):695-701. PubMed ID: 26256898
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Trigger mechanisms of secondary sclerosing cholangitis in critically ill patients.
    Leonhardt S; Veltzke-Schlieker W; Adler A; Schott E; Hetzer R; Schaffartzik W; Tryba M; Neuhaus P; Seehofer D
    Crit Care; 2015 Mar; 19(1):131. PubMed ID: 25886728
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gamma-glutamyltransferase is a strong predictor of secondary sclerosing cholangitis after lung transplantation for COVID-19 ARDS.
    Schwarz S; Lang C; Harlander M; Štupnik T; Slambrouck JV; Ceulemans LJ; Ius F; Gottlieb J; Kuhnert S; Hecker M; Aigner C; Kneidinger N; Verschuuren EA; Smits JM; Tschernko E; Schaden E; Faybik P; Markstaller K; Trauner M; Jaksch P; Hoetzenecker K
    J Heart Lung Transplant; 2022 Oct; 41(10):1501-1510. PubMed ID: 35907758
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Secondary sclerosing cholangitis in critically ill patients has a poor outcome but lower tumour incidence than primary sclerosing cholangitis.
    Kirstein MM; Book T; Manns MP; von Hahn T; Voigtländer T
    United European Gastroenterol J; 2020 Jul; 8(6):716-724. PubMed ID: 32366182
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Secondary Sclerosing Cholangitis Following Coronavirus Disease 2019 (COVID-19): A Multicenter Retrospective Study.
    Hunyady P; Streller L; Rüther DF; Groba SR; Bettinger D; Fitting D; Hamesch K; Marquardt JU; Mücke VT; Finkelmeier F; Sekandarzad A; Wengenmayer T; Bounidane A; Weiss F; Peiffer KH; Schlevogt B; Zeuzem S; Waidmann O; Hollenbach M; Kirstein MM; Kluwe J; Kütting F; Mücke MM
    Clin Infect Dis; 2023 Feb; 76(3):e179-e187. PubMed ID: 35809032
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Secondary sclerosing cholangitis in critically ill patients: a rare disease precipitated by severe SARS-CoV-2 infection.
    Edwards K; Allison M; Ghuman S
    BMJ Case Rep; 2020 Nov; 13(11):. PubMed ID: 33168538
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biliary Cast Syndrome and Secondary Sclerosing Cholangitis in Critically Ill Patient after Long-Term Treatment in the Intensive Care Unit.
    Alkurdi A; Herrmann J; Bikmukhametov D; Tschöpe R
    Case Rep Gastroenterol; 2024; 18(1):260-265. PubMed ID: 38737441
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Incidence of Secondary Sclerosing Cholangitis in Hospitalized Long COVID-19 Patients: A Retrospective Single Center Study.
    Werner CR; Fusco S; Kienzle K; Döbele S; Artzner K; Malek NP; Wichmann D; Göpel S
    Diagnostics (Basel); 2024 Mar; 14(7):. PubMed ID: 38611659
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Secondary sclerosing cholangitis after COVID-19 pneumonia: a report of two cases and review of the literature.
    Bauer U; Pavlova D; Abbassi R; Lahmer T; Geisler F; Schmid RM; Ehmer U
    Clin J Gastroenterol; 2022 Dec; 15(6):1124-1129. PubMed ID: 35953614
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Secondary sclerosing cholangitis in a young COVID-19 patient resulting in death: A case report.
    Steiner J; Kaufmann-Bühler AK; Fuchsjäger M; Schemmer P; Talakić E
    World J Gastrointest Surg; 2022 Dec; 14(12):1411-1417. PubMed ID: 36632122
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Endoscopic Characterization and Outcome of COVID-19 Patients with Secondary Sclerosing Cholangitis: A Case Series of a Tertiary Center.
    Hofstetter P; Zuber-Jerger I; Mehrl A; Graf B; Lunz D; Lubnow M; Müller T; Schmid S; Müller M; Kandulski A
    J Gastrointestin Liver Dis; 2024 Jun; 33(2):218-225. PubMed ID: 38944874
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.